Marketing-authorisation holder · United States
Btcp Pharma
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| LAZANDA0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Spray, metered | Fentanyl | United States | Not marketed | 2011 |
| SUBSYS0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.6MG **Federal Regist · Spray | Fentanyl | United States | Not marketed | 2012 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |